71131 Sigma-AldrichpETcoco™-1 System - Novagen
Novagen's pETcoco™ System combines the advantages of T7 promoter-driven protein expression with the ability to control plasmid copy number.
More>> Novagen's pETcoco™ System combines the advantages of T7 promoter-driven protein expression with the ability to control plasmid copy number. Less<<pETcoco™-1 System - Novagen : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
Produits recommandés
Aperçu
| Replacement Information |
|---|
Prix & Disponibilité
| Référence | Disponibilité | Conditionnement | Qté | Prix | Quantité | |
|---|---|---|---|---|---|---|
| 71131-3 |
|
Ampoule plast. | 1 kit |
|
— |
| Description | |
|---|---|
| Overview | The pETcoco™ System combines the advantages of T7 promoter-driven protein
expression with the ability to control plasmid copy number (Sektas 2003). In
the presence of 0.2% glucose, pETcoco™ recombinant plasmids are maintained at
one copy per cell. In this single-copy state, pETcoco clones are extremely stable because
background expression and consequent gene rearrangements or deletions are virtually
absent. For plasmid preparation, the copy number can be amplified to approximately 40
copies per cell independently of target gene expression by addition of L-arabinose to the
culture medium. Both target gene expression and plasmid plus insert amplification
are induced upon addition of IPTG. Both pETcoco-1 and pETcoco-2 vectors feature
an N-terminal His•Tag and internal S•Tag™ sequences, both of which are cleavable by enterokinase, and an optional C-terminal HSV•Tag sequence. NovaF- Competent Cells for cloning target genes and Tuner™(DE3) Competent Cells for expression are supplied with the pETcoco-1 and pETcoco-2 Systems.
Coexpression The pETcoco-1 plasmid contains a pET vector-compatible origin of replication and chloramphenicol resistance marker, making it suitable for transformation into cells already containing ampicillin- or kanamycin-resistant pET or pETDuet™-1 recombinants to enable the coexpression of multiple target genes in the same cell. The ampicillin-resistant pETcoco-2 plasmid is compatible with pET host strains supplying rare codon tRNAs and/or T7 lysozyme on a chloramphenicol-resistant plasmid, and with kanamycin-resistant pET recombinants for coexpression purposes. pETcoco-2 may also be used for coexpression with pACYCDuet™-1 recombinants with appropriate host strains. 
Commercial use of this Product requires a commercial license from EMD Millipore Corporation. Commercial use shall include but not be limited to (1) use of the Product or its components in manufacturing; (2) use of the Product or its components to provide a service, information, or data to others in exchange for consideration; (3) use of the Product or its components (or any derivatives thereof) for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the Product or its components, whether or not such Product or its components are resold for use in research. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of this Product. |
| This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges MilliporeSigma to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form. | |
| Catalogue Number | 71131 |
| Brand Family | Novagen® |
| Features and benefits |
|
| References | |
|---|---|
| References | Sektas, M. and Szybalski, W. 2003. inNovations 14, 6. |
| Product Information | |
|---|---|
| Components | |
| Fusion tag | His•Tag, S•Tag, HSV•Tag |
| Vector family | pETcoco |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information |
|---|
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Storage and Shipping Information | |
|---|---|
| Ship Code | Dry Ice Only |
| Toxicity | Multiple Toxicity Values, refer to MSDS |
| Storage | ≤ -70°C |
| Do not freeze | Ok to freeze |
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Référence | GTIN |
| 71131-3 | 04055977254709 |
Documentation
pETcoco™-1 System - Novagen FDS
| Titre |
|---|
pETcoco™-1 System - Novagen Certificats d'analyse
| Titre | Numéro de lot |
|---|---|
| 71131 |
Références bibliographiques
| Aperçu de la référence bibliographique |
|---|
Sektas, M. and Szybalski, W. 2003. inNovations 14, 6. |
Citations
| Titre | |
|---|---|
|
|
Protocoles Utilisateur
| Titre |
|---|
| TB053 Academic and Non-profit Laboratory Assurance Letter |
| TB333 pETcoco™ System |
Carte des vecteurs
| Titre |
|---|
| TB331VM pETcoco™-1 Vector Map |